chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Patient said the shot hurt during administration of the pediatric COVID-19 vaccine. She put her head down by her legs while seated in the chair. She then rolled over onto the floor. Patient came to within seconds. She laid down for a couple of minutes, then sat back up and drank some water.  Then waited 30 minutes for observation. Likely injection anxiety.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Paracentesis, Pericardial effusion, Pericardial excision
Clinical narrative: Two days after vaccination patient developed sudden onset shortness of breath. He was sent to the hospital for a paracentesis related to a pericardial effusion on 12/7/21. Three days later the fluid has reaccumulated and he has now undergone a pericardial window. Patient states they were heading to restaurant and stopped at the store for their booster shot.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient was give  0.5 ml of Moderna as a booster dose.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pain, Headache, Uveitis
Clinical narrative: Event: Uveitis in left eye Treatment: Durezol, steroid drops to the eye Outcome: currently pains inside the eyeball and has headache
Age: 77.0
Sex: M
Vaccine: VARZOS
Symptoms: Arthralgia, Back pain, Chest pain, Disturbance in attention, Dizziness
Clinical narrative: Overall feeling of illness, dizziness, fever,  pain in chest  shoulders and back,  chest pain when breathing-in.  These difficulties continue on still today. This was a severe adverse reaction making me incapable of working or concentrating, and causing short temperedness from the pain.
Age: 77.0
Sex: M
Vaccine: VARZOS
Symptoms: Impaired work ability, Malaise, Pyrexia
Clinical narrative: Overall feeling of illness, dizziness, fever,  pain in chest  shoulders and back,  chest pain when breathing-in.  These difficulties continue on still today. This was a severe adverse reaction making me incapable of working or concentrating, and causing short temperedness from the pain.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Enteritis, Gait inability, Joint swelling, Platelet count increased
Clinical narrative: After receiving  the booster (3rd) dose of moderna covid vaccine on 11/29/21, the patient began to develop a rash a few days later.  The rash worsened, so patient went to his PCP who put him on oral steroids.  A few days later the patient developed enteritis and was admitted to this hospital.   He was hospitalized for 5 days/4 nights and then released home.  He returns today with significant swelling and pain in multiple joints - unable to ambulate.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, White blood cell count increased
Clinical narrative: After receiving  the booster (3rd) dose of moderna covid vaccine on 11/29/21, the patient began to develop a rash a few days later.  The rash worsened, so patient went to his PCP who put him on oral steroids.  A few days later the patient developed enteritis and was admitted to this hospital.   He was hospitalized for 5 days/4 nights and then released home.  He returns today with significant swelling and pain in multiple joints - unable to ambulate.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Eye swelling, Incorrect route of product administration, Pruritus, Rash
Clinical narrative: Severe rash, erythema of the face, rash throughout the body except for the site of injection was not red, warm, nor presented with any rash. The patient states her body was itchy, upon checking her face was swelling red and her patchy eye lif slightly swollen. Although concern was lessened because she fought severely and cried for 25 minutes straight before the injection occurred in the thigh. Thus, Thuy gave her children diphenhydramine 5 mL and observed her for 30 minutes. She was hyper and very vocal after the diphenhydramine, she ate pretzels and drank 8 Fl. oz water.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Severe rash, erythema of the face, rash throughout the body except for the site of injection was not red, warm, nor presented with any rash. The patient states her body was itchy, upon checking her face was swelling red and her patchy eye lif slightly swollen. Although concern was lessened because she fought severely and cried for 25 minutes straight before the injection occurred in the thigh. Thus, Thuy gave her children diphenhydramine 5 mL and observed her for 30 minutes. She was hyper and very vocal after the diphenhydramine, she ate pretzels and drank 8 Fl. oz water.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Sinusitis
Clinical narrative: Facial numbness up to the right eye, swelling of the nasal cavity 25 minutes after injection. Benadryl stopped the progression.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine Administration error .   The Pfizer COVID 19 vaccine for 12 and older purple cap was drawn up in a syringe on 12/08/21. at 4 P.M.  scheduled to expire at 10 P.M. on 12/08/21.  The syringe was left in the refrigerator at the end of the day instead of being tossed out.  The next day on 12/09/21 the vaccinator administered the vaccine to the patent on 12/09/21 at 10 A.M.  Per the CDC's vaccine administration error and deviation sheet it instructs to call the manufacturer  I called Pfizer and spoke to Pfizer's medical outreach team .  Interaction# 00509123.  Off label information.  Not the recommenation.  Per Pfizer physical and stability studies.  The Pfizer COVID 19 vaccine maintains stability in the syringe in the refrigerator for 24 hours.  Do not have to revaccinate the patient.   The vaccine was in the refrigerator for 12 hours.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Client came to get booster dose of Moderna and received it earlier than the 6 month span from dose #2 Moderna.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Alanine aminotransferase increased, Amylase, Aspartate aminotransferase normal, Asymptomatic COVID-19
Clinical narrative: 21 yo female with no significant PMH who presented on 10/29 with 2 weeks of abdominal pain. Found to be COVID positive (asymptomatic, not hypoxic) and elevated LFTs. Extensive workup for abdominal pain done including pelvic U/S (showing simple cyst in the R ovary without torsion), RUQ U/S (without gallstones but focal fluid collecting abutting the right kidney), CT a/p (showing fluid-filled colon reflecting diarrhea with previously noted fluid collection on U/S corresponding with fluid filled colon), repeat pelvic U/S (showing normal bilateral adnexa). Further workup revealed acute porphyria (found to have high spot urine porphobilinogen). Hematology consulted and started on hemin infusions. Received 5 doses of hemin in house (last dose 11/10). Hospital course notable infusion related phlebitis secondary to hemin. Course also notable for urticaria with IV iron sucrose infusion (added to allergy list). Abdominal pain was an ongoing issue, but closer to discharge pt no longer requiring IV dilaudid. Pt to discharge home with pain regimen with close follow-up with hematology.   Patient Active Hospital Problem List:  ACUTE INTERMITTENT PORPHYRIA (11/6/2021)/ ABDOMINAL PAIN (10/29/2021)   Assessment: Pt presenting with abdominal pain. Several imaging studies including RUQ U/S, pelvic U/S unremarkable. CT a/p showing fluid filled colon reflecting diarrhea. Found to have porphyria. Query triggered by COVID infection.   Plan:  - appreciate heme recs             - s/p 5 doses of hemin (last dose 11/10) - encourage carb intake - continue pain control             - tylenol ATC, prn tramdol             - continue notriptyline, gabapentin             - lidocaine gel, voltaren gel, motrin prn for phlebitis pain Reason for Hospital Admission (Admitting Diagnosis):  Abdominal pain Acute porphyria
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Blood alkaline phosphatase normal, Blood bilirubin normal, Blood iron decreased, Computerised tomogram abdomen abnormal, Diarrhoea
Clinical narrative: 21 yo female with no significant PMH who presented on 10/29 with 2 weeks of abdominal pain. Found to be COVID positive (asymptomatic, not hypoxic) and elevated LFTs. Extensive workup for abdominal pain done including pelvic U/S (showing simple cyst in the R ovary without torsion), RUQ U/S (without gallstones but focal fluid collecting abutting the right kidney), CT a/p (showing fluid-filled colon reflecting diarrhea with previously noted fluid collection on U/S corresponding with fluid filled colon), repeat pelvic U/S (showing normal bilateral adnexa). Further workup revealed acute porphyria (found to have high spot urine porphobilinogen). Hematology consulted and started on hemin infusions. Received 5 doses of hemin in house (last dose 11/10). Hospital course notable infusion related phlebitis secondary to hemin. Course also notable for urticaria with IV iron sucrose infusion (added to allergy list). Abdominal pain was an ongoing issue, but closer to discharge pt no longer requiring IV dilaudid. Pt to discharge home with pain regimen with close follow-up with hematology.   Patient Active Hospital Problem List:  ACUTE INTERMITTENT PORPHYRIA (11/6/2021)/ ABDOMINAL PAIN (10/29/2021)   Assessment: Pt presenting with abdominal pain. Several imaging studies including RUQ U/S, pelvic U/S unremarkable. CT a/p showing fluid filled colon reflecting diarrhea. Found to have porphyria. Query triggered by COVID infection.   Plan:  - appreciate heme recs             - s/p 5 doses of hemin (last dose 11/10) - encourage carb intake - continue pain control             - tylenol ATC, prn tramdol             - continue notriptyline, gabapentin             - lidocaine gel, voltaren gel, motrin prn for phlebitis pain Reason for Hospital Admission (Admitting Diagnosis):  Abdominal pain Acute porphyria
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Gastrointestinal disorder, Haematocrit decreased, Haemoglobin decreased, Infusion related reaction, Intra-abdominal fluid collection
Clinical narrative: 21 yo female with no significant PMH who presented on 10/29 with 2 weeks of abdominal pain. Found to be COVID positive (asymptomatic, not hypoxic) and elevated LFTs. Extensive workup for abdominal pain done including pelvic U/S (showing simple cyst in the R ovary without torsion), RUQ U/S (without gallstones but focal fluid collecting abutting the right kidney), CT a/p (showing fluid-filled colon reflecting diarrhea with previously noted fluid collection on U/S corresponding with fluid filled colon), repeat pelvic U/S (showing normal bilateral adnexa). Further workup revealed acute porphyria (found to have high spot urine porphobilinogen). Hematology consulted and started on hemin infusions. Received 5 doses of hemin in house (last dose 11/10). Hospital course notable infusion related phlebitis secondary to hemin. Course also notable for urticaria with IV iron sucrose infusion (added to allergy list). Abdominal pain was an ongoing issue, but closer to discharge pt no longer requiring IV dilaudid. Pt to discharge home with pain regimen with close follow-up with hematology.   Patient Active Hospital Problem List:  ACUTE INTERMITTENT PORPHYRIA (11/6/2021)/ ABDOMINAL PAIN (10/29/2021)   Assessment: Pt presenting with abdominal pain. Several imaging studies including RUQ U/S, pelvic U/S unremarkable. CT a/p showing fluid filled colon reflecting diarrhea. Found to have porphyria. Query triggered by COVID infection.   Plan:  - appreciate heme recs             - s/p 5 doses of hemin (last dose 11/10) - encourage carb intake - continue pain control             - tylenol ATC, prn tramdol             - continue notriptyline, gabapentin             - lidocaine gel, voltaren gel, motrin prn for phlebitis pain Reason for Hospital Admission (Admitting Diagnosis):  Abdominal pain Acute porphyria
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Iron binding capacity total increased, Lipase normal, Liver function test increased, Nutritional supplement allergy, Ovarian cyst
Clinical narrative: 21 yo female with no significant PMH who presented on 10/29 with 2 weeks of abdominal pain. Found to be COVID positive (asymptomatic, not hypoxic) and elevated LFTs. Extensive workup for abdominal pain done including pelvic U/S (showing simple cyst in the R ovary without torsion), RUQ U/S (without gallstones but focal fluid collecting abutting the right kidney), CT a/p (showing fluid-filled colon reflecting diarrhea with previously noted fluid collection on U/S corresponding with fluid filled colon), repeat pelvic U/S (showing normal bilateral adnexa). Further workup revealed acute porphyria (found to have high spot urine porphobilinogen). Hematology consulted and started on hemin infusions. Received 5 doses of hemin in house (last dose 11/10). Hospital course notable infusion related phlebitis secondary to hemin. Course also notable for urticaria with IV iron sucrose infusion (added to allergy list). Abdominal pain was an ongoing issue, but closer to discharge pt no longer requiring IV dilaudid. Pt to discharge home with pain regimen with close follow-up with hematology.   Patient Active Hospital Problem List:  ACUTE INTERMITTENT PORPHYRIA (11/6/2021)/ ABDOMINAL PAIN (10/29/2021)   Assessment: Pt presenting with abdominal pain. Several imaging studies including RUQ U/S, pelvic U/S unremarkable. CT a/p showing fluid filled colon reflecting diarrhea. Found to have porphyria. Query triggered by COVID infection.   Plan:  - appreciate heme recs             - s/p 5 doses of hemin (last dose 11/10) - encourage carb intake - continue pain control             - tylenol ATC, prn tramdol             - continue notriptyline, gabapentin             - lidocaine gel, voltaren gel, motrin prn for phlebitis pain Reason for Hospital Admission (Admitting Diagnosis):  Abdominal pain Acute porphyria
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Phlebitis, Platelet count normal, Porphyria acute, SARS-CoV-2 test positive
Clinical narrative: 21 yo female with no significant PMH who presented on 10/29 with 2 weeks of abdominal pain. Found to be COVID positive (asymptomatic, not hypoxic) and elevated LFTs. Extensive workup for abdominal pain done including pelvic U/S (showing simple cyst in the R ovary without torsion), RUQ U/S (without gallstones but focal fluid collecting abutting the right kidney), CT a/p (showing fluid-filled colon reflecting diarrhea with previously noted fluid collection on U/S corresponding with fluid filled colon), repeat pelvic U/S (showing normal bilateral adnexa). Further workup revealed acute porphyria (found to have high spot urine porphobilinogen). Hematology consulted and started on hemin infusions. Received 5 doses of hemin in house (last dose 11/10). Hospital course notable infusion related phlebitis secondary to hemin. Course also notable for urticaria with IV iron sucrose infusion (added to allergy list). Abdominal pain was an ongoing issue, but closer to discharge pt no longer requiring IV dilaudid. Pt to discharge home with pain regimen with close follow-up with hematology.   Patient Active Hospital Problem List:  ACUTE INTERMITTENT PORPHYRIA (11/6/2021)/ ABDOMINAL PAIN (10/29/2021)   Assessment: Pt presenting with abdominal pain. Several imaging studies including RUQ U/S, pelvic U/S unremarkable. CT a/p showing fluid filled colon reflecting diarrhea. Found to have porphyria. Query triggered by COVID infection.   Plan:  - appreciate heme recs             - s/p 5 doses of hemin (last dose 11/10) - encourage carb intake - continue pain control             - tylenol ATC, prn tramdol             - continue notriptyline, gabapentin             - lidocaine gel, voltaren gel, motrin prn for phlebitis pain Reason for Hospital Admission (Admitting Diagnosis):  Abdominal pain Acute porphyria
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Serum ferritin increased, Transferrin saturation decreased, Ultrasound abdomen abnormal, Ultrasound pelvis abnormal, Urine porphobilinogen increased
Clinical narrative: 21 yo female with no significant PMH who presented on 10/29 with 2 weeks of abdominal pain. Found to be COVID positive (asymptomatic, not hypoxic) and elevated LFTs. Extensive workup for abdominal pain done including pelvic U/S (showing simple cyst in the R ovary without torsion), RUQ U/S (without gallstones but focal fluid collecting abutting the right kidney), CT a/p (showing fluid-filled colon reflecting diarrhea with previously noted fluid collection on U/S corresponding with fluid filled colon), repeat pelvic U/S (showing normal bilateral adnexa). Further workup revealed acute porphyria (found to have high spot urine porphobilinogen). Hematology consulted and started on hemin infusions. Received 5 doses of hemin in house (last dose 11/10). Hospital course notable infusion related phlebitis secondary to hemin. Course also notable for urticaria with IV iron sucrose infusion (added to allergy list). Abdominal pain was an ongoing issue, but closer to discharge pt no longer requiring IV dilaudid. Pt to discharge home with pain regimen with close follow-up with hematology.   Patient Active Hospital Problem List:  ACUTE INTERMITTENT PORPHYRIA (11/6/2021)/ ABDOMINAL PAIN (10/29/2021)   Assessment: Pt presenting with abdominal pain. Several imaging studies including RUQ U/S, pelvic U/S unremarkable. CT a/p showing fluid filled colon reflecting diarrhea. Found to have porphyria. Query triggered by COVID infection.   Plan:  - appreciate heme recs             - s/p 5 doses of hemin (last dose 11/10) - encourage carb intake - continue pain control             - tylenol ATC, prn tramdol             - continue notriptyline, gabapentin             - lidocaine gel, voltaren gel, motrin prn for phlebitis pain Reason for Hospital Admission (Admitting Diagnosis):  Abdominal pain Acute porphyria
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: 21 yo female with no significant PMH who presented on 10/29 with 2 weeks of abdominal pain. Found to be COVID positive (asymptomatic, not hypoxic) and elevated LFTs. Extensive workup for abdominal pain done including pelvic U/S (showing simple cyst in the R ovary without torsion), RUQ U/S (without gallstones but focal fluid collecting abutting the right kidney), CT a/p (showing fluid-filled colon reflecting diarrhea with previously noted fluid collection on U/S corresponding with fluid filled colon), repeat pelvic U/S (showing normal bilateral adnexa). Further workup revealed acute porphyria (found to have high spot urine porphobilinogen). Hematology consulted and started on hemin infusions. Received 5 doses of hemin in house (last dose 11/10). Hospital course notable infusion related phlebitis secondary to hemin. Course also notable for urticaria with IV iron sucrose infusion (added to allergy list). Abdominal pain was an ongoing issue, but closer to discharge pt no longer requiring IV dilaudid. Pt to discharge home with pain regimen with close follow-up with hematology.   Patient Active Hospital Problem List:  ACUTE INTERMITTENT PORPHYRIA (11/6/2021)/ ABDOMINAL PAIN (10/29/2021)   Assessment: Pt presenting with abdominal pain. Several imaging studies including RUQ U/S, pelvic U/S unremarkable. CT a/p showing fluid filled colon reflecting diarrhea. Found to have porphyria. Query triggered by COVID infection.   Plan:  - appreciate heme recs             - s/p 5 doses of hemin (last dose 11/10) - encourage carb intake - continue pain control             - tylenol ATC, prn tramdol             - continue notriptyline, gabapentin             - lidocaine gel, voltaren gel, motrin prn for phlebitis pain Reason for Hospital Admission (Admitting Diagnosis):  Abdominal pain Acute porphyria
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Scan
Clinical narrative: Swelling, sourness in left foot
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Gave the pediatric Pfizer vaccine to her when she should have gotten the adult dose.  She came with her siblings who are under 12 and asked to be added in.  Pharmacist did not realize that she was 15 and failed to confirm age prior to vaccination.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Ophthalmological examination abnormal, Photopsia, Vitreous detachment
Clinical narrative: Posterior Vitreous Detachment - Flashing lights in perpherial vision
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Decreased appetite
Clinical narrative: Patient described all over joint pain and no appetite starting evening of booster dose and continuing four days later with no improvement.  Patient is taking Naproxen and Acetaminophen for the joint pain and trying to stay hydrated. Patient stated he experienced similar symptoms after second dose in April and continued to feel poorly all summer. Patient has no autoimmune disorders diagnosed at the present time.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hyperhidrosis, Loss of consciousness, Pallor, Syncope
Clinical narrative: PATIENT RECEIVED VACCINE AT 230PM, AROUND 240PM, SHE APPEARED PALE AND SWEATING. PT STATED SHE FELT AS SHE WAS GOING TO FAINT. FAINTED MINUTES LATER. PROVIDED A INSTANT COLD PACK TO COOL PT, PT WOKE UP AND LAID DOWN, WHICH SHE STATED HELPED HER FEEL BETTER. EMS ARRIVED TO EVALUATE PT, PATIENT LEFT 30 MINUTES OR SO AFTER THE EVENT ALERT AND FINE
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram, Aphasia, Electrocardiogram, Full blood count, Metabolic function test
Clinical narrative: Profound expressive aphasia lasting several hours, then resolving over course of ED stay, with otherwise non-focal neurologic examination
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin
Clinical narrative: Profound expressive aphasia lasting several hours, then resolving over course of ED stay, with otherwise non-focal neurologic examination
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pain in extremity
Clinical narrative: Throughout the day my arm had felt a little sore. Within the last two hours I am in serious pain in the area of the injection site. This started out of the clear blue!
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Hyperhidrosis, Illness
Clinical narrative: Chills, nausea, sweating, body joint and muscle pain, headache, increased tinnitus, too sick to take my daughter to school
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Tinnitus
Clinical narrative: Chills, nausea, sweating, body joint and muscle pain, headache, increased tinnitus, too sick to take my daughter to school
Sex: U
Vaccine: COVID19
Symptoms: Cerebrovascular accident
Clinical narrative: suffered stroke after J&J vaccine
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Pain, Pain in extremity, Peripheral swelling, X-ray abnormal
Clinical narrative: The pain started in my right thumb and index finger, and it traveled up my arm about midway. It gradually got worse and worse.  It's real stiff in the morning, I put warm water and heating pad, it would make it feel better and it would just eventually get worse and worse and worse. That's why I went to the urgent care on 11/29 and had x-rays and was put on prednisone for 6 days and had a brace on it. It was better than it was, it's sore now and not like it was. There was also a point where I had swelling in my fingers at one point, but I do not have that anymore.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Incorrect dose administered
Clinical narrative: Patient was given 0.5 ml Im of Moderna as a booster dose.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulation drug level above therapeutic, Deep vein thrombosis, Hyperkalaemia, Hypotension, International normalised ratio increased
Clinical narrative: she had a 2nd moderna on 7/7/2021 lot 027B21A  my note from 23 Sep 2021: She is a 70-year-old woman with progression of right upper extremity DVT to the right innominate vein from the right IJ, progressed since July 2021, who has been on Coumadin most recently at least since July 2021, (I believe she was on Coumadin remotely in the past associated with GI bleed, polyps seen on lower endoscopy, and epistaxis, in the remote past due to A. Fib I think).  With also evidence of left cephalic vein thrombosis in September 2020, and left AV fistula occlusion status post angioplasty with some cephalic vein thrombosis in April 2021, and right IJ DVT in July 2021, with progression to the right innominate vein in September 2021.  She was admitted after missing dialysis with hyperkalemia and subsequent supratherapeutic INR, s/p vit K, and hypotension, off pressors now, INR 3.0 today, with history of vaginal bleeding on Provera and negative endometrial biopsies in the past.   Atrial fibrillation: Per cardiology, potentially was going to consider watchman in the past?   History of recurrent thrombosis: Do believe she is likely a good candidate for indefinite anticoagulation, however with difficulty remaining therapeutic on INRs and with her hemodialysis would consider apixaban 2.5 mg twice daily, however would not add until INR <2.0, would check INRs daily   Vaginal bleeding: She has been on Provera, endometrial biopsies have been negative, do recommend follow-up with gynecology prn   ESRD on HD
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Jugular vein occlusion
Clinical narrative: she had a 2nd moderna on 7/7/2021 lot 027B21A  my note from 23 Sep 2021: She is a 70-year-old woman with progression of right upper extremity DVT to the right innominate vein from the right IJ, progressed since July 2021, who has been on Coumadin most recently at least since July 2021, (I believe she was on Coumadin remotely in the past associated with GI bleed, polyps seen on lower endoscopy, and epistaxis, in the remote past due to A. Fib I think).  With also evidence of left cephalic vein thrombosis in September 2020, and left AV fistula occlusion status post angioplasty with some cephalic vein thrombosis in April 2021, and right IJ DVT in July 2021, with progression to the right innominate vein in September 2021.  She was admitted after missing dialysis with hyperkalemia and subsequent supratherapeutic INR, s/p vit K, and hypotension, off pressors now, INR 3.0 today, with history of vaginal bleeding on Provera and negative endometrial biopsies in the past.   Atrial fibrillation: Per cardiology, potentially was going to consider watchman in the past?   History of recurrent thrombosis: Do believe she is likely a good candidate for indefinite anticoagulation, however with difficulty remaining therapeutic on INRs and with her hemodialysis would consider apixaban 2.5 mg twice daily, however would not add until INR <2.0, would check INRs daily   Vaginal bleeding: She has been on Provera, endometrial biopsies have been negative, do recommend follow-up with gynecology prn   ESRD on HD
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products, Paraesthesia oral, Pharyngeal swelling, Throat irritation, Throat tightness
Clinical narrative: Patient is a 50 year old female who has completed a 30-minute observation period with the following signs and symptoms of an adverse reaction: sensation of throat swelling or throat closure, tingling in the tip of the tongue, itching in the throat. Janssen/J&J COVID-19 vaccine #2 in series administered.   Patient received moderna as first dose on 1/7/21 at a satellite clinic per patient. Patient had numbness on left side of face and arm after getting moderna but did not go to emergency. Numbness went away per pateint. Msg was sent to doctor and was advised to take J&J to complete vaccination.  Patient here for j and J vaccine Upon examination, no swelling of lips noted, no tongue swelling, throat is clear. Voice is clear, speaking in full sentences. No audible wheezing noted. No rash, no hives. Vital signs as follows Vitals:  12/10/21 1407 12/10/21 1412 12/10/21 1420 12/10/21 1430 BP: (!) 143/90  122/84 124/78 Pulse: 77 72 71 71 Resp: 20 18 20 18 SpO2: 100% 100% 100% 100%     Action(s) taken: Another drug administered - Benadryl 25 mg PO x1 Allergy to COVID-19 vaccine documented in Allergies activity: No, advised to see doctor for advise.  Patient advised to discuss second dose considerations with a clinician Sent home at 230pm. Feeling better.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Pain
Clinical narrative: fatigue, pain, lack of energy
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Entire face started tingling about 5 hrs after injection. Cntinued for 3 days of tingling for 1-3 hours then would go away for about 2 hours before coming back. After the 3rd day, left side of face is numb, no longer tingling. The numbness is constant and has not got any better over the past 20 hours.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Pt came into the HCF locally to request his Moderna Booster.  He did not have his card.  He provided a state driver's license.    Staff member A assisted him with application completion.  Staff member B looked up information on the computer to make out vaccination card.   His first vaccine 6/2/21, second vaccine was 10/29/21.  Card was  given to the client.  He took his form to the vaccination table and was given third shot booster.  During check out by staff member D, it was determined that his second vaccine was in October. Staff member C informed me that the booster was given too early. I advised the client to notify his primary care physician.    I notified My Manager and Director, I called client at 3:30 and he stated he was doing well.  No signs of any reaction.
Age: 39.0
Sex: F
Vaccine: UNK
Symptoms: Anticoagulant therapy, Deep vein thrombosis, Ultrasound Doppler abnormal
Clinical narrative: she had covid vaccine and about a wk later developed RLE DVT, this was at outside heme office and i don't have records and was given anticoagulation for 3 mos w/ improvement, but LE DVT was related to covid shot
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Vaccination error
Clinical narrative: This is not an adverse event.  It was a vaccination error.  The patient was given the Moderna vaccinations 21 days apart instead of the approved 28 days.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Pt stated she felt dixxy after receiving the vaccine. BP: 102/68 02: 100% HR:88
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Appendicectomy, Appendicitis
Clinical narrative: Appendicitis requiring appendectomy
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Bone pain, Chills, Gastric disorder, Myalgia
Clinical narrative: Nausea, vertigo, fever, chills, muscle pain, bone pain, joint pain, knuckles popping, stomach issues
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vertigo
Clinical narrative: Nausea, vertigo, fever, chills, muscle pain, bone pain, joint pain, knuckles popping, stomach issues
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Angiogram abnormal, Anticoagulant therapy, Cholecystectomy, Computerised tomogram abdomen abnormal
Clinical narrative: She had a Pfizer Covid vaccine 3 March 2021, and her second dose 15 June 2021 and a booster 27 September 2021 She had gastric sleeve with cholecystectomy 23 March 2021 1 week later she started having significant diarrhea and abdominal pain which ultimately prompted a  CT abdomen pelvis 13 April 2021 showing extensive near occlusive portal vein thrombosis with SMV thrombosis, she began Lovenox CT abdomen pelvis 23 April 2021 showed no significant change to subtle decrease in extensive portal vein thrombosis CT angio 10 June 2021 showed stable portal vein thrombosis CT abdomen pelvis 8 July 2021 showed no significant change in portal vein thrombosis, no lymphadenopathy, trace ascites, mild colonic thickening/stranding CT abdomen pelvis 20 September 2021 showed partially occlusive thrombus through portal vein system, no significant change, with secondary colonic thickening and stranding likely secondary to thrombosis  During this process, due to ongoing diarrhea 14-16 times per day she was started on TPN but since TPN has been discontinued and she is back on a healthy diet, also aspirin 81 mg daily had been added, DOAC is being avoided due to history of bariatric surgery, no family history of thrombosis
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Gastrectomy, Gastrointestinal wall thickening, Mesenteric vein thrombosis, Portal vein thrombosis
Clinical narrative: She had a Pfizer Covid vaccine 3 March 2021, and her second dose 15 June 2021 and a booster 27 September 2021 She had gastric sleeve with cholecystectomy 23 March 2021 1 week later she started having significant diarrhea and abdominal pain which ultimately prompted a  CT abdomen pelvis 13 April 2021 showing extensive near occlusive portal vein thrombosis with SMV thrombosis, she began Lovenox CT abdomen pelvis 23 April 2021 showed no significant change to subtle decrease in extensive portal vein thrombosis CT angio 10 June 2021 showed stable portal vein thrombosis CT abdomen pelvis 8 July 2021 showed no significant change in portal vein thrombosis, no lymphadenopathy, trace ascites, mild colonic thickening/stranding CT abdomen pelvis 20 September 2021 showed partially occlusive thrombus through portal vein system, no significant change, with secondary colonic thickening and stranding likely secondary to thrombosis  During this process, due to ongoing diarrhea 14-16 times per day she was started on TPN but since TPN has been discontinued and she is back on a healthy diet, also aspirin 81 mg daily had been added, DOAC is being avoided due to history of bariatric surgery, no family history of thrombosis
Age: 19.0
Sex: F
Vaccine: HEP
Symptoms: Incorrect dose administered
Clinical narrative: MD had originally ordered the peds dose but later placed order for the 2 dose adult dose (11-15 yo), by mistake. All of these orders were available to use. This error was not caught during chart review.   Patient got the peds dose in June, based on the original order (0-19 yo). This was correct. However was incorrectly given the adult dose for the 2nd dose. This error was not discovered until reviewing her chart for the 3rd dose.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Patient had a fever.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Autoimmune disorder, Pneumonia, Pulmonary thrombosis
Clinical narrative: Pneumonia with blood clots in right lung, and suddenly I was told I had a new autoimmune disease when I was concerned the vax caused this as I was fine before, just a bit of allergies going on due to my pets.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling, Lymphadenopathy, Pyrexia
Clinical narrative: The staff member c/o fever, swollen lymph node  in the L axilla as well as local swelling and redness at vaccination site.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Cough, Fatigue, Injection site pain, Pain
Clinical narrative: fever, coughing, exhaustion, extreme body and leg pai. injection site was not sore until day 4/5 and now the bicep muscle is very painful
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: fever, coughing, exhaustion, extreme body and leg pai. injection site was not sore until day 4/5 and now the bicep muscle is very painful
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Dyspnoea, Electrocardiogram normal, Fatigue
Clinical narrative: About 24 hours after the shot, I was extremely chilled all over and very tired. I went to bed and tossed and turned half of the night. I woke up in the middle of the night with a fever and took Tylenol to decrease my temp (high was 101.1F). That morning (12/2) I was having chest pressure and my heart rate was elevated anytime I stood up. I stayed home from work to rest. That evening (12/2) I took an IBPROFEN and the pressure seemed a little better. The next morning (12/3) my heart rate was still elevated when standing or doing anything besides laying down (135bpm while brushing my teeth) and I couldn't seem to catch my breath. I stayed home from work and went to Urgent care at about 10AM that day (Friday 12/3).
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Impaired work ability, Influenza virus test negative, Poor quality sleep, Pyrexia
Clinical narrative: About 24 hours after the shot, I was extremely chilled all over and very tired. I went to bed and tossed and turned half of the night. I woke up in the middle of the night with a fever and took Tylenol to decrease my temp (high was 101.1F). That morning (12/2) I was having chest pressure and my heart rate was elevated anytime I stood up. I stayed home from work to rest. That evening (12/2) I took an IBPROFEN and the pressure seemed a little better. The next morning (12/3) my heart rate was still elevated when standing or doing anything besides laying down (135bpm while brushing my teeth) and I couldn't seem to catch my breath. I stayed home from work and went to Urgent care at about 10AM that day (Friday 12/3).
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative
Clinical narrative: About 24 hours after the shot, I was extremely chilled all over and very tired. I went to bed and tossed and turned half of the night. I woke up in the middle of the night with a fever and took Tylenol to decrease my temp (high was 101.1F). That morning (12/2) I was having chest pressure and my heart rate was elevated anytime I stood up. I stayed home from work to rest. That evening (12/2) I took an IBPROFEN and the pressure seemed a little better. The next morning (12/3) my heart rate was still elevated when standing or doing anything besides laying down (135bpm while brushing my teeth) and I couldn't seem to catch my breath. I stayed home from work and went to Urgent care at about 10AM that day (Friday 12/3).
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Antinuclear antibody positive, Biopsy bone marrow abnormal, Bladder hypertrophy, Blood bilirubin increased, Blood copper normal
Clinical narrative: Had moderna covid vaccines 1 Mar and 30 Mar 2021.  Noted epistaxis, headache, subconjunctival hemorrhages, headaches worsened.  Presented in 7/27/21 from PCP office with headache and was found to have bilateral SDH and platelets of 1k. He was treated with IVIG and steroids as well as 3 units of platelets. Platelets recovered to ~100k and patient underwent subdural evacuation with neurosurgery.  7/29/21: BMBx showed slightly hypercellular bone marrrow (50% cellularity) with slightly increased erythropoesis and granulopoesis and slightly decreased megakaryopoesis. No morphologic or immunophenotypic features of a myelodysplastic syndrome.  His platelet response was not sustained by the inital treatments with IVIG and steroids and he required intermittent platelet transfusions as an outpatient to try to keep platelets >50k as per neurosurgery. Spleen was normal size on exam and US.   Vitamin B12, folate, zinc and copper levels were WNL, HIV neg, ANA+, hepatitis a and C negative, hep B core IgM and surface antigen negative, hep B core antibody had been positive, DAT was negative on 21 September though it had been positive on 17 September 2021 for IgG, zinc had been low, creatinine normal, bilirubin 1.4, LDH 362, TSH suppressed at 0.055, 17 September 2021 haptoglobin was less than 8, 24 September 2021 white count 12.2, platelets 13, hemoglobin 9.7 with platelets of 13 and MCV of 107.  He was started on Eltrombopag 25 mg daily early Sep 2021 and was then increased to 50 mg daily, stopped after a couple wks due to lack of response. Reports of lack of response w/ romiplostim too in house. His platelet count decreased to 7k. Patient was admitted and received IVIG and solumedrol 60 mg q8hr IV as well as 8 units of platelets. Platelets only increased to 13k. Getting HLA matched plts.  He was then started on rituximab weekly x 4, completed 10/4/21. Most recent platelet count from 10/4/21 was 18k. He was also started on mycophenylate 500 mg BID in late September 2021 w/ prednisone 60 mg daily.  9/15/21: Repeat BMBx done due to low platelet counts and showed moderately hypercellular bone marrow with mild erythroid hyperplasia, megakaryocytic hypoplasia and minimal dyspoesis, negative for marrow infiltrative process  He denies use of heparin or quinine or significant antibiotics or Tylenol or NSAIDs or excess walnuts or medicinal teas or EBV or ulcers or malaria or other chronic infections or significant joint pains  CT head 27 July 2021 showed 2.1 cm right subdural hematoma CT chest 27 July 2021 with moderate peri and infrahilar bronchial thickening, suggestive of bronchitis Ultrasound of the spleen 28 July 2021 normal size spleen, liver 16 cm with hepatic steatosis 10 September 2021 CT head with significant decrease in right subdural hematoma 12 September 2021 CT abdomen pelvis spleen normal, mild bladder wall thickening, no lymphadenopathy
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatinine normal, Blood erythropoietin increased, Blood lactate dehydrogenase increased, Blood thyroid stimulating hormone decreased, Blood zinc decreased
Clinical narrative: Had moderna covid vaccines 1 Mar and 30 Mar 2021.  Noted epistaxis, headache, subconjunctival hemorrhages, headaches worsened.  Presented in 7/27/21 from PCP office with headache and was found to have bilateral SDH and platelets of 1k. He was treated with IVIG and steroids as well as 3 units of platelets. Platelets recovered to ~100k and patient underwent subdural evacuation with neurosurgery.  7/29/21: BMBx showed slightly hypercellular bone marrrow (50% cellularity) with slightly increased erythropoesis and granulopoesis and slightly decreased megakaryopoesis. No morphologic or immunophenotypic features of a myelodysplastic syndrome.  His platelet response was not sustained by the inital treatments with IVIG and steroids and he required intermittent platelet transfusions as an outpatient to try to keep platelets >50k as per neurosurgery. Spleen was normal size on exam and US.   Vitamin B12, folate, zinc and copper levels were WNL, HIV neg, ANA+, hepatitis a and C negative, hep B core IgM and surface antigen negative, hep B core antibody had been positive, DAT was negative on 21 September though it had been positive on 17 September 2021 for IgG, zinc had been low, creatinine normal, bilirubin 1.4, LDH 362, TSH suppressed at 0.055, 17 September 2021 haptoglobin was less than 8, 24 September 2021 white count 12.2, platelets 13, hemoglobin 9.7 with platelets of 13 and MCV of 107.  He was started on Eltrombopag 25 mg daily early Sep 2021 and was then increased to 50 mg daily, stopped after a couple wks due to lack of response. Reports of lack of response w/ romiplostim too in house. His platelet count decreased to 7k. Patient was admitted and received IVIG and solumedrol 60 mg q8hr IV as well as 8 units of platelets. Platelets only increased to 13k. Getting HLA matched plts.  He was then started on rituximab weekly x 4, completed 10/4/21. Most recent platelet count from 10/4/21 was 18k. He was also started on mycophenylate 500 mg BID in late September 2021 w/ prednisone 60 mg daily.  9/15/21: Repeat BMBx done due to low platelet counts and showed moderately hypercellular bone marrow with mild erythroid hyperplasia, megakaryocytic hypoplasia and minimal dyspoesis, negative for marrow infiltrative process  He denies use of heparin or quinine or significant antibiotics or Tylenol or NSAIDs or excess walnuts or medicinal teas or EBV or ulcers or malaria or other chronic infections or significant joint pains  CT head 27 July 2021 showed 2.1 cm right subdural hematoma CT chest 27 July 2021 with moderate peri and infrahilar bronchial thickening, suggestive of bronchitis Ultrasound of the spleen 28 July 2021 normal size spleen, liver 16 cm with hepatic steatosis 10 September 2021 CT head with significant decrease in right subdural hematoma 12 September 2021 CT abdomen pelvis spleen normal, mild bladder wall thickening, no lymphadenopathy
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Bronchial wall thickening, Bronchitis, Computerised tomogram head abnormal, Computerised tomogram thorax abnormal, Conjunctival haemorrhage
Clinical narrative: Had moderna covid vaccines 1 Mar and 30 Mar 2021.  Noted epistaxis, headache, subconjunctival hemorrhages, headaches worsened.  Presented in 7/27/21 from PCP office with headache and was found to have bilateral SDH and platelets of 1k. He was treated with IVIG and steroids as well as 3 units of platelets. Platelets recovered to ~100k and patient underwent subdural evacuation with neurosurgery.  7/29/21: BMBx showed slightly hypercellular bone marrrow (50% cellularity) with slightly increased erythropoesis and granulopoesis and slightly decreased megakaryopoesis. No morphologic or immunophenotypic features of a myelodysplastic syndrome.  His platelet response was not sustained by the inital treatments with IVIG and steroids and he required intermittent platelet transfusions as an outpatient to try to keep platelets >50k as per neurosurgery. Spleen was normal size on exam and US.   Vitamin B12, folate, zinc and copper levels were WNL, HIV neg, ANA+, hepatitis a and C negative, hep B core IgM and surface antigen negative, hep B core antibody had been positive, DAT was negative on 21 September though it had been positive on 17 September 2021 for IgG, zinc had been low, creatinine normal, bilirubin 1.4, LDH 362, TSH suppressed at 0.055, 17 September 2021 haptoglobin was less than 8, 24 September 2021 white count 12.2, platelets 13, hemoglobin 9.7 with platelets of 13 and MCV of 107.  He was started on Eltrombopag 25 mg daily early Sep 2021 and was then increased to 50 mg daily, stopped after a couple wks due to lack of response. Reports of lack of response w/ romiplostim too in house. His platelet count decreased to 7k. Patient was admitted and received IVIG and solumedrol 60 mg q8hr IV as well as 8 units of platelets. Platelets only increased to 13k. Getting HLA matched plts.  He was then started on rituximab weekly x 4, completed 10/4/21. Most recent platelet count from 10/4/21 was 18k. He was also started on mycophenylate 500 mg BID in late September 2021 w/ prednisone 60 mg daily.  9/15/21: Repeat BMBx done due to low platelet counts and showed moderately hypercellular bone marrow with mild erythroid hyperplasia, megakaryocytic hypoplasia and minimal dyspoesis, negative for marrow infiltrative process  He denies use of heparin or quinine or significant antibiotics or Tylenol or NSAIDs or excess walnuts or medicinal teas or EBV or ulcers or malaria or other chronic infections or significant joint pains  CT head 27 July 2021 showed 2.1 cm right subdural hematoma CT chest 27 July 2021 with moderate peri and infrahilar bronchial thickening, suggestive of bronchitis Ultrasound of the spleen 28 July 2021 normal size spleen, liver 16 cm with hepatic steatosis 10 September 2021 CT head with significant decrease in right subdural hematoma 12 September 2021 CT abdomen pelvis spleen normal, mild bladder wall thickening, no lymphadenopathy